Sanofi
MicroRNA Compounds and Methods for Modulating MIR-21 Activity

Last updated:

Abstract:

Described herein are compositions and methods for the inhibition of miR-21 activity. The compositions have certain nucleoside modification patterns that yield potent inhibitors of miR-21 activity. The compositions may be used to inhibit miR-21, and also to treat diseases associated with abnormal expression of miR-21, such as fibrosis and cancer.

Status:
Application
Type:

Utility

Filling date:

18 Aug 2021

Issue date:

31 Mar 2022